Inmed Pharmaceuticals In (IN.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 9,806 | 9,685 | 11,400 | 13,461 | 18,350 |
| Marketable Securities | 3,934 | 5,572 | 5,453 | 5,716 | 1,781 |
| Receivables | 65 | 58 | 34 | 16 | 41 |
| TOTAL | $14,129 | $15,801 | $17,151 | $19,356 | $20,327 |
| Non-Current Assets | |||||
| PPE Net | 43 | 36 | 38 | 39 | 42 |
| Intangibles | 902 | 903 | 901 | 968 | 968 |
| TOTAL | $945 | $938 | $939 | $1,007 | $1,011 |
| Total Assets | $15,074 | $16,739 | $18,090 | $20,363 | $21,338 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,190 | 500 | 404 | 457 | 713 |
| TOTAL | $1,190 | $500 | $404 | $457 | $713 |
| Non-Current Liabilities | |||||
| TOTAL | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $1,190 | $500 | $404 | $457 | $713 |
| Shareholders' Equity | |||||
| Common Shares | 52,239 | 51,269 | 49,984 | 52,692 | 51,748 |
| Retained earnings | -49,185 | -45,162 | -41,710 | -41,916 | -39,017 |
| TOTAL | $13,883 | $16,239 | $17,686 | $19,906 | $20,625 |
| Total Liabilities And Equity | $15,074 | $16,739 | $18,090 | $20,363 | $21,338 |